Alex Adams

Dr. Alex Adams


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2016 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
AAAlex Adams
Alex Adams
KWKrystalyn K. Weaver
Krystalyn K. Weaver
Recently momentum has been building behind pharmacist prescriptive authority for certain products such as oral contraceptives or naloxone. To some, prescriptive authority by pharmacists represents a departure from the traditional role of pharmacists in dispensing medications. Nearly all states, however, currently enable pharmacist prescriptive authority in some form or fashion. The variety of different state approaches makes it difficult for pharmacists to ascertain the pros and cons of different models. We leverage data available from the National Alliance of State Pharmacy Associations (NASPA), a trade association that tracks pharmacy legislation and regulations across all states, to characterize models of pharmacist prescriptive authority along a continuum from most restrictive to least restrictive. We identify 2 primary categories of current pharmacist prescriptive authority: (1) collaborative prescribing and (2) autonomous prescribing. Collaborative prescribing models provide a broad framework for the treatment of acute or chronic disease. Current autonomous prescribing models have focused on a limited range of medications for which a specific diagnosis is not needed. Approaches to pharmacist prescriptive authority are not mutually exclusive. We anticipate that more states will pursue the less-restrictive approaches in the years ahead.

1 May 2016 in Journal of Managed Care & Specialty Pharmacy
Verified
Journal Article
Open access
AAAlex Adams
Alex Adams
SSSamuel F. Stolpe
Samuel F. Stolpe
Poor medication adherence has been increasingly recognized as a major public health issue and a priority for health care reform. Primary medication nonadherence (PMN) is a subset of this broader subject and occurs when a new medication is prescribed for a patient, but the patient does not obtain the medication, or an appropriate alternative, within an acceptable period of time after it was prescribed. It is increasingly evident that the public health problem of PMN is widespread. However, the lack of standardized definitions and measures inhibits the ability to establish the true incidence of this problem or to track changes in PMN rates over time. Given the limitations of current measures, the Pharmacy Quality Alliance (PQA) convened an expert working group to set parameters for a new industry measure. That new measure, which links electronic prescribing and pharmacy dispensing databases and was developed and approved by the PQA, is described here. PMN literature from 1990 to June 2015 is also reviewed, ...

1 July 2016 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
MKMichael E. Klepser
Michael E. Klepser
AAAlex Adams
Alex Adams
PSPaul Srnis
Paul Srnis
MMMatthew Mazzucco
Matthew Mazzucco
DKDonald Klepser
Donald Klepser

1 January 2018 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
AAAlex Adams
Alex Adams

8 July 2020 in Pharmacy
Verified
Journal Article
Open access
PDF file
AAAlex Adams
Alex Adams
Pharmacist prescriptive authority continues to increase at the state level in the United States. Recently, the Idaho Board of Pharmacy (BOP) finalized regulations that expanded autonomous prescriptive authority in its state to a range of preventative care as well as acute and chronic conditions. This manuscript reviews the key decision points made by the BOP regarding drug categories included, education requirements, protocols, access to data, and use of standards of care. Overall, Idaho’s approach closely reflects the medical model of regulation and may prove useful to other states and jurisdictions as they consider similar issues.

13 August 2020 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
PDF file
AAAlex Adams
Alex Adams
KWKrystalyn K. Weaver
Krystalyn K. Weaver
To fully engage in the Pharmacists’ Patient Care Process, pharmacists must be able to (1) participate in a Collaborative Practice Agreement, (2) order and interpret laboratory tests, (3) prescribe certain medications, (4) adapt medications, (5) administer medications, and (6) effectively delegate tasks to support staff. Each of these activities is dependent on state scope of practice laws, but these laws are not binary. Various state-level restrictions allow us to view these activities on a continuum from more restrictive to less restrictive. This continuum will allow pharmacy and public health stakeholders to identify priorities for action in their states.